Antibody purification using membrane adsorbers

BioPharm International

Volumn 21, Issue 12, 2008, Pages 48-52

  Giovannoni, Leonardo ^a   Ventani, Marco ^a   Gottschalk, Uwe ^b  

^a Philogen SpA   (Italy)

^b SARTORIUS STEDIM BIOTECH GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY;

ADSORPTION; AFFINITY CHROMATOGRAPHY; ANION EXCHANGE CHROMATOGRAPHY; ANTIBODY TITER; ARTICLE; ARTIFICIAL MEMBRANE; BIOTECHNOLOGY; COLUMN CHROMATOGRAPHY; COMPUTER PROGRAM; COST EFFECTIVENESS ANALYSIS; DRUG INDUSTRY; DRUG PURIFICATION; DRUG PURITY; DRUG RESEARCH; DRUG SYNTHESIS; ELUTION; EQUIPMENT DESIGN; EUROPEAN UNION; FILTRATION; FLOW RATE; MEDICAL TECHNOLOGY; NANOTECHNOLOGY; POROSITY; PROTEIN PURIFICATION; REPRODUCIBILITY; ROOM TEMPERATURE; STANDARDIZATION; VALIDATION PROCESS;

EID: 59649117154     PISSN: 1542166X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Daemmrich A, Browden ME. A rising drug industry. Chem Eng News. 2005;Jun:28-42.
2. Gottschalk U. New and unknown challenges facing biomanufacturing. BioPharm Int. 2005; 18(3):24-28.
3. Thoemmes J, Kula MR. Membrane chromatography. An integrative concept in the downstream processing of proteins. Biotechnol Prog. 1995;11:357-367.
4. Zhou J, Tressel T. Basic concepts in Q membrane chromatography for large-scale antibody production. Biotechnol Prog. 2006;22:341-349.
5. Etzel M, Riordan W. Membrane chromatography: Analysis of breakthrough curves and viral clearance. In: Shukla A, Etzel M, Gadam S, editors. Process Scale Bioseparations for the Biopharmaceutical Industry. Boca Raton, FL: Taylor & Francis;2006.
6. Walter JK. Strategies and considerations for advanced economy in downstream processing of biopharmaceutical proteins. In: Subramanian G, editor. Bioseparation and bioprocessing. processing, quality and characterization, economics, safety and hygiene. New York: Wiley VCH; 1998. p. 447-460.
7. Gebauer KH, Thömmes J. Kula MR. Breakthrough performance of high-capacity membrane adsorbers in protein chromatography. Chem. Eng Sci. 1997;52:405-419.
8. Gottschalk U. Bioseparation in antibody manufacturing: The good, the bad and the ugly. Biotechnol Prog. 2008 (in press).
9. Norling L, et al. Impact of multiple reuse of anion exchange chromatography media on virus removal. J Chromatogr. 2005;1069:79-89.
10. Zhou JX, et al. New Q membrane scale-down model for process-scale antibody purification. J Chromatogr A. 2006;1134,66-73.
11. Marlind J, et al. Clin Cancer Res. 2008 Oct 15;14(20):6515-24.
12. Zhou J, Tressel T. Q membrane chromatography as a robust purification unit for large-scale antibody production. BioProcess Intl. 2005;3(suppl):32-37.
13. Kelley B. Very large scale monoclonal antibody purification: the case for conventional unit operations. Biotechnol Prog. 2007;23:995-1008.
14. Curling J, Gottschalk U. Process chromatography: Five decades of innovation. BioPharm Int. 2007;20:10-19.